222 related articles for article (PubMed ID: 30941881)
1. The effectiveness of imiquimod 5% cream as an anti-wrinkle treatment: A pilot study.
Altalhab S
J Cosmet Dermatol; 2019 Dec; 18(6):1729-1732. PubMed ID: 30941881
[TBL] [Abstract][Full Text] [Related]
2. Novel topical dermal repair: A clinical analysis.
Yeh LC; Gonzalez N; Goldberg DJ
J Cosmet Dermatol; 2019 Aug; 18(4):1025-1029. PubMed ID: 31120173
[TBL] [Abstract][Full Text] [Related]
3. Anti-aging proof of concept study: results and summary.
Bruce S; Karnik J; Dryer L; Burkholder D
J Drugs Dermatol; 2014 Sep; 13(9):1074-81. PubMed ID: 25226008
[TBL] [Abstract][Full Text] [Related]
4. Global periorbital skin rejuvenation by a topical eye cream containing low molecular weight heparan sulfate (LMW-HS) and a blend of naturally derived extracts.
Colvan L; Fleck T; Vega VL
J Cosmet Dermatol; 2019 Apr; 18(2):530-538. PubMed ID: 30636356
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Tolerability of a Retinoid Eye Cream for Fine to Moderate Wrinkles of the Periorbital Region.
Kaufman J; Callender V; Young C; Jones P; Wortzman M; Nelson D
J Drugs Dermatol; 2022 Sep; 21(9):932-937. PubMed ID: 36074511
[TBL] [Abstract][Full Text] [Related]
6. Single-Center, Double-Blind, Randomized, Placebo-Controlled, Study of the Efficacy and Safety of a Cream Formulation for Improving Facial Wrinkles and Skin Quality.
Sadick N; Bohnert K; Serra M; Kitchen N
J Drugs Dermatol; 2018 Jun; 17(6):664-669. PubMed ID: 29879254
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive evaluation of the efficacy and safety of a new multi-component anti-aging topical eye cream.
Yang F; Zhang X; Wang H; Guo M; Zhang J; Feng X; Yu J; Yang J; Zhu J; Wang Y
Skin Res Technol; 2024 Jul; 30(7):e13790. PubMed ID: 38932444
[TBL] [Abstract][Full Text] [Related]
8. Confirmed efficacy of topical nifedipine in the treatment of facial wrinkles.
Calabrò G; De Vita V; Patalano A; Mazzella C; Lo Conte V; Antropoli C
J Dermatolog Treat; 2014 Aug; 25(4):319-25. PubMed ID: 23688162
[TBL] [Abstract][Full Text] [Related]
9. Visualization and treatment of subclinical actinic keratoses with topical imiquimod 5% cream: an observational study.
Kopera D; Kerl H
Biomed Res Int; 2014; 2014():135916. PubMed ID: 24900953
[TBL] [Abstract][Full Text] [Related]
10. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
[TBL] [Abstract][Full Text] [Related]
11. Tretinoin (0.05% cream vs. 5% peel) for photoaging and field cancerization of the forearms: randomized, evaluator-blinded, clinical trial.
Sumita JM; Miot HA; Soares JLM; Raminelli ACP; Pereira SM; Ogawa MM; Picosse FR; Guadanhim LRS; Enokihara MMSS; Leonardi GR; Bagatin E
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1819-1826. PubMed ID: 29704456
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses.
Stockfleth E; Meyer T; Benninghoff B; Salasche S; Papadopoulos L; Ulrich C; Christophers E
Arch Dermatol; 2002 Nov; 138(11):1498-502. PubMed ID: 12437457
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Efficacy of a Skin Care Regimen Containing Methyl Estradiolpropanoate (MEP) for Treating Estrogen Deficient Skin.
Cohen JL
J Drugs Dermatol; 2019 Dec; 18(12):1226-1230. PubMed ID: 31860210
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Swanson N; Smith CC; Kaur M; Goldenberg G
J Drugs Dermatol; 2014 Feb; 13(2):166-9. PubMed ID: 24509967
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of a double-conjugated retinoid cream vs 1.0% retinol cream or 0.025% tretinoin cream in subjects with mild to severe photoaging.
McDaniel DH; Mazur C; Wortzman MS; Nelson DB
J Cosmet Dermatol; 2017 Dec; 16(4):542-548. PubMed ID: 28762645
[TBL] [Abstract][Full Text] [Related]
16. Comparison of topical antiaging creams in the management of lateral canthal lines.
Carroll JM; Hanna S; Guenther LC; Boucher N
J Cosmet Dermatol; 2020 Mar; 19(3):694-704. PubMed ID: 31350814
[TBL] [Abstract][Full Text] [Related]
17. Effect of a preparation containing a fucose-rich polysaccharide on periorbital wrinkles of human voluntaries.
Robert C; Robert AM; Robert L
Skin Res Technol; 2005 Feb; 11(1):47-52. PubMed ID: 15691259
[TBL] [Abstract][Full Text] [Related]
18. Retinyl retinoate, a novel hybrid vitamin derivative, improves photoaged skin: a double-blind, randomized-controlled trial.
Kim H; Koh J; Baek J; Seo Y; Kim B; Kim J; Lee J; Ryoo H; Jung H
Skin Res Technol; 2011 Aug; 17(3):380-5. PubMed ID: 21435021
[TBL] [Abstract][Full Text] [Related]
19. Pilot, Multicenter, Open-Label Evaluation of Safety, Tolerability and Efficacy of a Novel, Topical Multipotent Growth Factor Formulation for the Periorbital Region.
Sundaram H; Gold M; Waldorf H; Lupo M; Nguyen VL; Karnik J
J Drugs Dermatol; 2015 Dec; 14(12):1410-7. PubMed ID: 26659933
[TBL] [Abstract][Full Text] [Related]
20. An open-label, single-site study to evaluate the tolerability, safety, and efficacy of using a novel facial moisturizer for preparation and accelerated healing pre and post a single full-face radiofrequency microneedling treatment.
Zahr AS; Kononov T; Sensing W; Biron JA; Gold MH
J Cosmet Dermatol; 2019 Feb; 18(1):94-106. PubMed ID: 30456804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
